This is archived content from the U.S. Department of Justice website. The information here may be outdated and links may no longer function. Please contact webmaster@usdoj.gov if you have any questions about the archive site.

Justice Department Delivers New Opioid Policy Announcement

Tuesday, February 27, 2018

Attorney General Sessions announced a new Prescription Interdiction & Litigation Task Force and that the Department of Justice will be filing a Statement of Interest in a multi-district action regarding hundreds of lawsuits against opioid manufacturers and distributors. He was joined in this announcement by Arkansas Attorney General Leslie Rutledge, Utah Attorney General Sean Reyes, Ohio Attorney General Mike DeWine, West Virginia Attorney General Patrick Morrisey, Texas Attorney General Ken Paxton, Wisconsin Attorney General Brad Schimel, and Pennsylvania Attorney General Josh Shapiro.

Attorney General Sessions announces the Prescription Interdiction and Litigation Force
Ohio Attorney General Mike DeWine delivers remarks
Pennsylvania Attorney General Josh Shapiro delivers remarks.
West Virginia Attorney General Patrick Morrisey delivers remarks.
Wisconsin Attorney General Brad Schimel delivers remarks.
Texas Attorney General Ken Paxton delivers remarks.
Arkansas Attorney General Leslie Rutledge delivers remarks.
Utah Attorney General Sean Reyes delivers remarks.
It is the resolute policy of this Administration and this Department of Justice to reduce these overdose deaths, to reduce addiction, and to reduce the amount of prescription opioids in this county
Related: 

Justice Department to File Statement of Interest in Opioid Case
Attorney General Sessions Announces New Prescription Interdiction & Litigation Task Force
Attorney General Sessions Delivers Remarks Announcing the Prescription Interdiction and Litigation Task Force

Updated January 20, 2021